Nachrichten zur Hims & Hers Health Inc. Aktie

Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill

In recent days, Amazon Pharmacy announced it would begin offering Novo Nordisk’s Wegovy once-daily weight-loss pill through both insurance and…

Is It Too Late To Consider Hims & Hers Health (HIMS) After Its 4x Three-Year Surge?

This article examines what the current share price of Hims & Hers Health may be implying about the company, and…

Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today

In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $32.34, indicating a +2.05% shift from…

Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $32.34, moving +2.05% from the previous trading…

Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today

In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $32.34, indicating a +2.05% shift from…

Hims & Hers Expands Platform-Led Access to Provider-Directed Care

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers stock is crashing: will it rebound soon?

Hims & Hers stock has nosedived in the past few months. It has dived by over 56% from its highest…

Evercore ISI Initiates Coverage on Hims (HIMS) with In-Line Rating

Key Takeaways Evercore ISI Group initiates coverage on Hims & Hers Health (HIMS) with an In-Line rating. Current…

Evercore ISI initiates Hims and Hers stock coverage with In Line rating By Investing.com

Evercore ISI initiates Hims and Hers stock coverage with In Line rating…

Evercore ISI initiates Hims and Hers stock coverage with In Line rating By Investing.com

Evercore ISI initiates Hims and Hers stock coverage with In Line rating…

Hims & Hers Health (HIMS) Receives Sell Rating Amid Overvaluation Concerns

Key Takeaways: Hims & Hers Health, Inc. (HIMS) faces valuation concerns with an elevated EV/EBIT ratio of…

Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next - TechStock²…

Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price Pullback

For investors wondering whether Hims & Hers Health still offers good value after its rise as a telehealth brand, or…

A Look At Hims & Hers Health (HIMS) Valuation As Telehealth And Recurring Care Draw Fresh Attention

Hims & Hers Health (HIMS) is back in focus as investors reassess its telehealth model, weighing GLP-1 related interest and…

Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Target Cut

Recent Stock Decline: Hims & Hers Health Inc. has seen its stock price drop recently, with a notable decline of…

Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears - TechStock²…

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill - TechStock²…

Hims & Hers Health: Capitalizing On Healthcare Innovation

…

Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill By Investing.com

Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill…

Hims & Hers CEO Bets On Personalized Healthcare And AI In 2026 — Wall Street Braces For A Costly Year

The development follows OpenAI’s rollout of ChatGPT Health, which helps users blend health information with AI-driven insights.…

Hims & Hers Growth Story Has A Lot To Prove In 2026

Hims & Hers stock is down 50% from all-time highs amid fading momentum in compounded GLP-1 offerings. Click here to…

Why Hims & Hers Health Stock Is Sliding Now

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based health and…

Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth

Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international expansion opportunities. Learn more…

2026: The Year of the Consumer in Healthcare

2026 is the year of the individual in healthcare, and we’ve built Hims & Hers to be the leader in…

Hims & Hers Health: Under-Appreciated Upside

…

Hims & Hers: A Rare GARP Setup After The Market Reset

…

Hims & Hers: Capitalizing On Robust Subscriber/ARPU Growth

Hims & Hers trades at FWD EV/Sales of 3.45x and FWD EV/EBITDA of 25.85x, with FY2030 targets implying further upside…

Hims & Hers Aktie: Achtung, Gegenwind!

New York (www.aktiencheck.de) - Hims & Hers-Aktienanalyse der Citigroup:Citi gehe davon aus, dass die heutige Ankündigung von Novo Nordisk ,…

Hims & Hers: Navigating a Shifting Landscape in Telehealth

Hims & Hers US4330001060…

Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts

Hims & Hers Health, Inc. (HIMS) reached $35.45 at the closing of the latest trading day, reflecting a +2.12% change…

Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts

Hims & Hers Health, Inc. (HIMS) reached $35.45 at the closing of the latest trading day, reflecting a +2.12% change…

Hims & Hers Health: Could Start To Look Interesting In 2026

Hims & Hers Health, Inc. analysis: subscription health platform growth, GLP-1 risks, and catalysts in women’s health & diagnostics. Click…

A Look At Hims & Hers Health (HIMS) Valuation As Insider Selling And Investor Caution Raise Questions

Recent attention on Hims & Hers Health (HIMS) centers on insider selling by senior executives and large position shifts by…

Hims & Hers Health Is Building A Hormonal Empire

Hims & Hers is down 30% but still a Buy: margin expansion, GLP-1 clarity, new hormone care, and global growth.…

Hims & Hers enters 2026 on solid ground — stock rises even after Novo Nordisk leaves it off Wegovy partner list

?Hims shares logged their best session in a month and added after-hours gains. ?Novo expanded oral Wegovy access, while Citi…

Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions data and AI as central to building…

Hims & Hers: A Great Moment To Buy The Dip

Hims & Hers is achieving tremendous revenue growth with a renewed Novo Nordisk weight loss partnership. Click here to read…

Hims & Hers Health Inc. Stock (HIMS) Opinions on Canadian Market Expansion

Canadian Expansion Buzz: Recent chatter on social media has spotlighted Hims & Hers Health Inc.s move into the Canadian market…

Hims & Hers Stock: Assessing the Valuation Question

Hims & Hers US4330001060…

Will Insider Selling And Institutional Buying Shift Hims & Hers Healths (HIMS) Valuation Debate And Narrative

In the past week, Hims & Hers Health has been under scrutiny as insider selling, institutional position shifts, and questions…

Hims & Hers Health (NYSE:HIMS) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, Volatility is not a risk we care about. What we care about…

Hims & Hers: Navigating Regulatory Headwinds and Operational Momentum

Hims & Hers US4330001060…

HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns

Hims & Hers Health(HIMS) just hit a rare 7-day losing streak. Is this crash a deep-value buy signal or…

$HIMS | How Hims & Hers Health Inc. Class A (#HIMS) Affects Rotational Strategy Timing (HIMS)

Price-action only: Hims & Hers Health Inc. Class A (HIMS) movements set the tone for institutional models. How Hims &…

Hims & Hers Continues Global Growth with Canadian Market Entry

Hims & Hers Health has officially launched operations in Canada, marking a notable step in its international expansion after completing…